A detailed history of Means Investment Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Means Investment Co., Inc. holds 27,554 shares of ABBV stock, worth $5.35 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
27,554
Previous 29,343 6.1%
Holding current value
$5.35 Million
Previous $5.34 Million 11.55%
% of portfolio
0.58%
Previous 0.69%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $276,919 - $323,379
-1,789 Reduced 6.1%
27,554 $4.73 Million
Q1 2024

Apr 17, 2024

SELL
$159.82 - $182.1 $31,484 - $35,873
-197 Reduced 0.67%
29,343 $5.34 Million
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $14,585 - $16,426
106 Added 0.36%
29,540 $4.58 Million
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $10,420 - $12,062
-78 Reduced 0.26%
29,434 $4.39 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $8,480 - $10,553
-64 Reduced 0.22%
29,512 $3.98 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $14,171 - $16,320
98 Added 0.33%
29,576 $4.71 Million
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $10,649 - $12,771
77 Added 0.26%
29,478 $0
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $53,952 - $61,879
-402 Reduced 1.35%
29,401 $3.95 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $29,725 - $37,791
-216 Reduced 0.72%
29,803 $4.57 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $6,598 - $8,187
50 Added 0.17%
30,019 $4.87 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $8,594 - $10,874
80 Added 0.27%
29,969 $4.06 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $4,788 - $5,435
-45 Reduced 0.15%
29,889 $3.22 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $23,777 - $26,489
226 Added 0.76%
29,934 $3.37 Million
Q1 2021

Apr 05, 2021

BUY
$102.3 - $112.62 $19,334 - $21,285
189 Added 0.64%
29,708 $3.22 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $84,112 - $113,560
1,045 Added 3.67%
29,519 $3.06 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $15,034 - $17,645
-175 Reduced 0.61%
28,474 $2.64 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $15,040 - $20,126
205 Added 0.72%
28,649 $2.66 Million
Q1 2020

Apr 23, 2020

SELL
$64.5 - $97.79 $7,611 - $11,539
-118 Reduced 0.41%
28,444 $2.32 Million
Q4 2019

Jan 21, 2020

SELL
$72.13 - $90.25 $17,166 - $21,479
-238 Reduced 0.83%
28,562 $2.51 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $818 - $984
13 Added 0.05%
28,800 $2.39 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $56,699 - $72,474
-863 Reduced 2.91%
28,787 $2.05 Million
Q1 2019

Apr 16, 2019

BUY
$77.14 - $90.79 $795,081 - $935,772
10,307 Added 53.29%
29,650 $2.39 Million
Q4 2018

Apr 16, 2019

BUY
$77.85 - $96.01 $1.51 Million - $1.86 Million
19,343 New
19,343 $1.78 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Means Investment Co., Inc. Portfolio

Follow Means Investment Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.